SYNOPSIS The blood lymphocytes from a case of prolymphocytic leukaemia were subjected to a battery of different tests in order to establish as certainly as possible their T or B cell type of origin. The results of the tests for surface markers indicated the T-cell origin of the leukaemic cells in this patient, and this provided a good opportunity to determine the participation of T cells in the various tests proposed for measuring human lymphocyte function.
Lymphocytes in both mice and man have been characterized as thymus (T) and bone marrow (B) derived on the basis of surface properties such as immunoglobulin staining (Papamichail, Brown, and Holborow, 1971; Froland, Natvig, and Berdal, 1971) , C3 receptors (Bianco, Patrick, and Nussenzweig, 1970) , Fc receptors (Dickler and Kunkel, 1972) , or the formation of rosettes with sheep red blood cells (Lay, Mendes, Bianco, and Nussenzweig, 1971; Jondal, Holm, and Wigzell, 1972; Papamichail, Keith, Currey, and Holborow, 1972) . It has also been found, particularly in rodents, that the two kinds of lymphocytes can respond differently to mitogens such as PPD and lipopolysaccharide (B cells) (Sultzer and Nilsson, 1972; Greaves and Janossy, 1972) , phytohaemagglutinin (PHA), Concanavalin A (Con A) (T cells), and pokeweed mitogen (PWM) (both T and B cells) (Greaves and Janossy, 1972) .
Studies of human lymphocytes in chronic lymphocytic leukaemia, applying a limited number of these criteria, have suggested the disease to be predominantly of B cells (Papamichail et al, 1971; Preud'homme and Seligman, 1972; Grey, Rabellino, and Pirofsky, 1971) . Prolymphocyticleukaemia in the majority of the cases studied is shown likewise to have B-cell characteristics. However, in one case which has ahready been reported in a preliminary manner (Catovsky, Galetto, Okos, Galton, Wiltshaw, and Stathopoulos, 1973) , there were indications that the cells were ofT-cell origin. In the present Received for publication 5 August 1974. investigation a battery of different tests for lymphocyte markers has been used in order to establish as certainly as possible the T-cell origin of the leukaemic cells in this patient.
Cinical Summary
A woman, R.R., aged 58 yr, presented to the Brompton Chest Hospital with fever, weakness, and dyspnoea of two months' duration. Examination revealed lymphadenopathy involving the neck, axillae, and inguinal regions. There was gross splenic enlargement. There was also evidence of chest infection and situs inversus.
Investigations were as follows: Hb 82%; white cell count 150 000/mm3 (97% lymphocytes, platelets 95000/mm3). Blood and marrow smears showed some abnormally large cells with prominent nucleoli.
A diagnosis of leukaemia of prolymphocytic type was made and prednisone 60 mg daily was prescribed, subsequently reduced and discontinued after two months.
At this stage the patient was transferred to the Royal Marsden Hospital. Investigations were as follows: haemoglobin (Hb) 10-9 g 100 ml; platelets 135 000/mm3; white cell count, 513 000/mm3 (96% cells were of prolymphocytic type).
A chest radiograph showed a right-sided pleural effusion.
Cytotoxic therapy was commenced as follows: (1) cyclophosphamide 500 mg intravenously once; (2) vincristine 2 mg intravenously repeated after one week; (3) asparaginase 10 000 units daily for 14 days.
There was slight regression in the size of lymph nodes and spleen. The pleural effusion receded. However the white cell count remained essentially unchanged and two weeks later the patient collapsed and died. Permission for necropsy was not given.
Methods

LYMPHOCYTE SEPARATION
Ten ml heparinized venous blood was added to an equal volume of Ficoll-Triosil and centrifuged at 2000 rpm for 20 minutes. The cells at the interphase were then washed three times in medium 199.
SPONTANEOUS ROSETTE-FORMING CELLS (SRFC) This test was performed by techniques which differed slightly between the Chester Beatty Institute and Taplow. The details of the test as performed at the latter institution are given in parentheses.
Sheep red blood cells were washed three times in normal saline and made up to a dilution of 0 5 % in medium 199 (normal saline). Of this cell suspension 0 25 ml (0 5 ml) was mixed in a plastic tube with 0 25 ml (0-6 ml) of the lymphoid cell suspension containing 4 x 106 cells/ml (3 x 106 cells/ml). Fetal calf serum, 0-05 ml, ie, 10%,was added and the tube incubated for five minutes at 37°C (10 minutes at room temperature), centrifuged at 1000 rpm for five minutes, and then incubated at 4°C for one hour (and 24 hours).
The cells were resuspended gently by hand (Matburn rotator) and 0-1 ml of a 10% dilution of glutaraldehyde in medium 199 was added to each tube (not done). Ox red blood cells (E) were thrice washed in phosphate-buffered saline (PBS), pH 7-4, and a 1 % suspension was made. To 1 ml of this suspension an equal volume of IgM rabbit anti-ox erythrocyte serum (A), diluted 1:40 in PBS was added, and incubated for 30 minutes at 37°C. The antibodycoated cells (EA) were then again thrice washed in PBS, and 1 ml of a 1 % suspension was incubated at 37°C for 30 minutes with an equal volume of fresh human serum diluted 1:20 in PBS as a source of C3 (C). The complement-treated cells (EAC) were then washed thrice in PBS and re-constituted to a 1 % suspension. Lymphocytes, 1-2 x 106, were added to 0-25 ml 1 % EAC, centrifuged at 1000 rpm for five minutes, and incubated at 37°C for 30 minutes. The cells were then re-suspended gently by hand, and one drop of suspension examined under a coverslip. An EAC rosette was defined as one lymphocyte with at least 3 EAC attached.
Mitogen responsiveness
The following mitogens were used: phytohaemagglutinin (PHA), concanavalin A (Con A), pokeweed mitogen (PWM), purified protein derivative (PPD), endotoxin, sodium periodate (NalO4). Dacie and Lewis (1963 Thomas, 1973) , rabbit antihuman T, and B blast sera (for specificity see Thomas and Phillips, 1973) were kindly supplied by Dr B. Thomas. These were incubated undiluted with the leukaemic cells, as above, and the appropriate fluorescein-conjugated antiserum was then applied.
Human aggregated Cohn fraction II gamma globulin solution (20 mg/ml) was diluted 1:4 in PBS and 0-2 ml incubated with 3 x 106 leukaemic cells for 30 minutes at 4°C. After washing, the cells were incubated with 1:5 antihuman fluoresceinated IgG (Wellcome Reagents), washed, and mounted.
Electron Microscope Observation
At the end of the incubation period of the sheep red cell rosette test the cell pellet was fixed in 1 % glutaraldehyde for one hour. Araldite sections were stained with a 2 % aqueous solution of uranyl acetate and lead citrate and examined in an AE1-6 electron microscope at 60 KV.
Serum Immunoglobulins
Routine cellulose acetate electrophoresis of the patients' serum was carried out. Quantitation was performed by the Mancini technique. 
Results
Discussion
The high spontaneous rosette count together with the high peripheral white cell count suggests a marked proliferation of T cells. The lack of surface Ig, C3, and aggregate receptors-recognized B cell markers-support this. Furthermore 92 % of the cells were stained by human anti-T cell serum after the addition of appropriate conjugate, and pretreatment with the same serum produced marked inhibition of rosette formation.
The lack of staining by anti T-or B-blast serum indicates that the cells were relatively mature although morphologically by both light microscopy and electron microscopy they were abnormal. Dr M. F. Greaves also kindly tested a sample of these leukaemic cells for B and T cell surface markers and found a complete absence of B markers. He confirmed the high SRFC rosette incidence, but with antihuman brain serum (for specificity see Greaves, Janossy, and Doenhoff, 1974) obtained no membrane staining, although with rabbit anti-T blast serum he found positive staining, in contrast to the anti-T blast result we obtained. It is possible that these two anti-T blast sera may have specificities for different antigenic phases of the T-ell cycle. The negative result with antibrain serum indicates that cells were not in the resting (G.) phase.
Functionally, the cells could be stimulated by polyclonal mitogens, which indicates that they had not previously undergone blast transformation. The best response was to PHA, generally considered to be a T cell mitogen (Greaves et al, 1974) . The lower response to con A may be due to the fact that this test was performed on cells obtained from the patient three days after cytotoxic treatment had been started, whereas the PHA test was done before.
The cells gave some response to pokeweed mitogen (PWM) and less to endotoxin. Pokeweed mitogen is known to be capable of stimulating both B and T cells in the mouse and in man (Greaves and Janossy, 1972; Greaves et al, 1974) . Endotoxin produces practically no stimulation of normal human peripheral lymphocytes (Peavy, Adler, and Smith, 1970) . The fact that in the present case it produced some response may be due to the cells not being in the resting phase of the cell cycle, and hence more readily responsive.
Purified protein derivative has been considered a non-specific B cell mitogen in mice not previously immunized (Sultzer and Nilsson, 1972) . In the present case, the cells gave no response to doses of 10 to 100 ,ug/ml. In contrast, control normal cells showed up to an eightfold increase in counts over the same dose range. NalO4 has been shown to stimulate normal peripheral blood lymphocytes (Parker etal, 1973) but the maximum response of the cells studied here was sharply delimited to a dose of 1 x 10-3 M. Further study of dose effects and cell type involved appear to be indicated.
It is unwise to be dogmatic about the selectivity of mitogens for human T and B cell populations, especially when, as in the present case, their effects have not been tested on separated B cells. Nevertheless the results in this case provide some information about the stimulatory properties of these mitogens on a naturally occurring population of almost pure T cells in man.
With regard to the PAS reaction, it has been reported that in mice it is predominantly T lymphoblasts which show positive cytoplasmic granules (Greaves and Janossy, 1972 (Papamichail et al, 1971; Preud'homme and Seligman, 1972; Grey et al, 1971 ), Burkitt's lymphoma (Klein, van Furth, Johansson, Emberg, and Clifford, 1972) , and other cases of prolymphocytic leukaemic (Catovsky et al, 1973) . In the case of prolymphocytic leukaemic investigated here, however, we have been able to assign the leukaemic cells to the T cell category with some certainty, thus adding to the few published case reports of T cell neoplasms. These include a Stemberg cell sarcoma (Smith, Barker, Clein, and Collins, 1973a) , in which, although of T-cell type, the cells were unresponsive to PHA, other T cell leukaemias (Lille, Desplaces, Meens, and Saracino, 1973; Dickler, Siegal, Bentwich, and Kunkel, 1973) , and acute lymphoblastic leukaemia (Smith, Terry, Buell, and Sell, 1973b) . The monocytoid cell in Sezary's reticulosis is also thought to be T-cell derived (Brouet, Flandrin, and Seligman, 1973) , but while the PAS-positive granules in the cytoplasm of Sezary cells are diastase resistant, ie, probably of mucopolysaccharide nature (Taswell and Winkelmann, 1961) , in our case the granules behaved like glycogen.
Knowledge of the type of the cell involved should improve understanding of the nature and prognosis of these disorders and might influence clinical management. It appears from the limited number of cases of T cell proliferation reported thus far that the outlook is considerably worse than with B cell disorders, with the notable exception of infectious mononucleosis which is probably a benign, selflimiting instance of T cell proliferation (Sheldon, Papamichail, Hemsted, and Holborow, 1973) .
